Manufacturing

Eirene Pharmaceuticals is striving to establish itself as a highly esteemed pharmaceutical company in India, focusing on formulation development and manufacturing. Our commitment lies in executing every task with excellence, emphasizing the importance of consistently performing ordinary tasks exceptionally well. We believe that excellence is not a singular act but a habitual practice, shaped by our repeated dedication to maintaining high standards in all endeavors.

Our vision is to persist as a pharmaceutical company centered on quality, driven by research, and dedicated to adhering strictly to CGMP while prioritizing environmental safety. We aim to make quality a habitual commitment evident at every stage, spanning production, testing, and marketing. Our guiding principle involves consistently doing the right thing in all circumstances.


Proudly positioned as a prominent leader in marketing CNS products and expanding influence in diverse therapeutic areas like cardiac, diabetic, and pain segments, the company aims to leverage its cost-effective manufacturing capabilities to produce specialty generic formulations with high-profit margins.


The manufacturing facilities feature a one-way flow for the movement of personnel and materials, ensuring a strict adherence to Good Manufacturing Practices (GMP) conditions. These facilities are equipped to produce a range of dosage forms, including tablets and capsules.

Each of the units functions in accordance with a Quality Management System (QMS) that aligns with international guidelines :-

  • Our facilities are equipped with autonomous and well-equipped Quality Control Laboratories, encompassing sections for instrumentation, chemical analysis, microbiology, and testing of packaging materials. Quality control procedures are managed through the Quality Laboratory Management System (QLMS), facilitating direct data capture from equipment to minimize human intervention and potential errors.
  • Specialized storage zones are established to accommodate raw materials, packing materials, and finished goods, adhering to specific storage condition requirements. Two stability centers, furnished with walk-in chambers, conduct stability studies for all zones in accordance with ICH guidelines.
  • The entire operational process, spanning from customer order entry to the dispatch of finished goods, is managed through an ERP system.
  • Comprehensive measures in Environment Health and Safety (EHS), aligned with global standards, are implemented, including the presence of an Effluent Treatment Plant, a Fire hydrants system, and an Emergency Response Plan, ensuring a secure and health-conscious workplace.

Research & Development

Eirene Pharmaceuticals is dedicated to the ongoing development of Bioequivalent Generics, employing top-tier research and maintaining stringent quality standards. Our research and development unit comprises more than 10 proficient and seasoned scientists and developers specializing in formulation and analytical development. We are steadfast in our dedication to creating innovative formulations across diverse dosage forms, with a particular emphasis on solid dosage and various tablet types.

Identification of New Products

  • Conceiving and identifying product profile
  • Pre-formulation studies
  • Lab formula development and development for stability & validation
  • Scale up for process optimization /validation
  • Analytical method development
  • Pilot-scale Manufacturing
  • Stability studies as per ICH guidelines
  • Dossier preparation for submission/Technical assistance for contract manufacturing/New product introduction in Market
  • Data management (for transfer to customer/ Regulatory Affairs)

The Forms of Dosage

The technologies and dosage formulations created by our R&D include :

  • Immediate Release Solid Dosage Form (IR)
  • Sustained Release tablet Technology (DR)
  • Enteric Coated Technology
  • Direct Compression Technology
  • Orodispersible tablet form
  • Chewable tablet form